Aug 11 2009
Somanetics Corporation (Nasdaq: SMTS), a developer, manufacturer and marketer of the INVOS(R) Cerebral/Somatic Oximeter, a medical device that monitors oxygen saturation in the brain and other regions of the body, announced that it has filed a patent infringement action against CAS Medical Systems, Inc. in the United States District Court for the Eastern District of Michigan.
The complaint asserts that CAS Medical's FORE-SIGHT(R) Cerebral Oximeter willfully infringes upon one or more of Somanetics' patents, including United States Patent Nos. 6,615,065, 5,902,235 and 5,482,034.
The complaint also asserts that CAS Medical has engaged in unfair competition and false advertising, by making false or misleading statements in connection with its advertising and promotion of FORE-SIGHT, and false or misleading statements related to Somanetics' products.
The complaint seeks, among other things, compensation for damages and an injunction against CAS Medical from infringing upon Somanetics' patents.
www.somanetics.com